Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

J&J Ordered To Pay $8 Bln In Case Over Male Breast Growth On Anti-psychotic Drug

RTTNews Wednesday, 9 October 2019 ()
A Philadelphia jury ordered that Johnson & Johnson (JNJ) must pay $8 billion in punitive damages to a man who claimed the company failed to warn that boys using its Risperdal anti-psychotic drug could grow breasts.
0
shares
ShareTweetSavePostSend
 
Credit: Reuters Studio - Published < > Embed
News video: Drugmakers in spotlight as GSK recalls Zantac

Drugmakers in spotlight as GSK recalls Zantac 01:18

Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.

Recent related videos from verified sources

Man who grew breasts after taking autism drug wins billions in damages [Video]Man who grew breasts after taking autism drug wins billions in damages

Man who grew breasts after taking autism drug wins billions in damages Nicholas Murray was prescribed the Anti-psychotic drug ‘Risperdal’ as a child, after he was diagnosed with autism. He alleges..

Credit: Wibbitz - Bang Entertainment     Duration: 01:06Published

Philadelphia Jury Issues $8 Billion Judgement Against Johnson & Johnson Over Drug Linked To Male Breast Growth [Video]Philadelphia Jury Issues $8 Billion Judgement Against Johnson & Johnson Over Drug Linked To Male Breast Growth

A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked..

Credit: CBS 3 Philly     Duration: 00:27Published


Recent related news from verified sources

Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its...
Reuters Also reported by •NewsmaxBusiness InsiderBBC NewsIndependentCBS News

Johnson & Johnson slapped with $8B verdict in lawsuit over antipsychotic drug Risperdal: Media Reports

Johnson & Johnson (NYSE:JNJ) has been ordered to pay $8 billion in punitive damages to a man who claims the company failed to warn him that antipsychotic drug...
Proactive Investors Also reported by •NYTimes.comBBC NewsIndependentCBS News

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.